La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding La Jolla Pharmaceutical Co changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 44 | 1 | 45 | +2 |
| Shares | 16.7M | 41.7K | 16.5M | −199.6K (−1.2%) |
| Value | $77.8M | $194.0K | $70.4M | −$7.20M (−9.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held La Jolla Pharmaceutical Co at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 90,441 | $386.0K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 33,632 | $144.0K | 0.00% |
| Ritholtz Wealth Management | 15,031 | $64.0K | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $43.0K | 0.03% |
| Meeder Asset Management Inc | 4,312 | $18.0K | 0.00% |
Sold out (3)
Institutions that held La Jolla Pharmaceutical Co at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Captrust Financial Advisors | 2,600 | $12.0K |
| Advisor Group Holdings, Inc. | 1,150 | $5.00K |
| Amplius Wealth Advisors, LLC | 1,255 | $5.00K |
Not filed for Q1 2022 yet (1)
Institutions that held La Jolla Pharmaceutical Co at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| First Midwest Bank Trust Division | 41,731 | $194.0K |